Skip to main content
Erschienen in: Uro-News 9/2019

31.08.2019 | Benigne Prostatahyperplasie | Zertifizierte Fortbildung

Neuer Therapieansatz für BPH/LUTS

Prostataarterienembolisation — Hintergrund, Technik und Ergebnisse

verfasst von: Prof. Dr. med. Thomas J. Vogl, Annette Zinn, Leona S. Alizadeh, Christian Booz, Nagy N. Naguib

Erschienen in: Uro-News | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Prostataarterienembolisation ist eine effektive und komplikationsarme Methode zur Therapie mindestens moderater Symptome des unteren Harntrakts mit wachsender Evidenz. Sie ist dabei nicht als Ersatz für die etablierten chirurgischen Verfahren für schwere Obstruktionen zu werten. Vielmehr sollte sie als Alternative bei Versagen der medikamentösen Therapie, als Therapieoption bei moderaten bis schweren Symptomen sowie als Möglichkeit für Patienten mit Kontraindikationen gegen ein operatives Vorgehen gesehen werden.
Literatur
1.
Zurück zum Zitat DeMeritt JS et al. Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization. J Vasc Interv Radiol. 2000; 11: 767–70CrossRef DeMeritt JS et al. Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization. J Vasc Interv Radiol. 2000; 11: 767–70CrossRef
2.
Zurück zum Zitat McWilliams JP et al. Society of Interventional Radiology Multisociety Consensus Position Statement on Prostatic Artery Embolization for Treatment of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: From the Society of Interventional Radiology, the Cardiovascular and Interventional Radiological Society of Europe, Société Française de Radiologie, and the British Society of Interventional Radiology: Endorsed by the Asia Pacific Society of Cardiovascular and Interventional Radiology, Canadian Association for Interventional Radiology, Chinese College of Interventionalists, Interventional Radiology Society of Australasia, Japanese Society of Interventional Radiology, and Korean Society of Interventional Radiology. J Vasc Interv Radiol 2019; 30: 627–37CrossRef McWilliams JP et al. Society of Interventional Radiology Multisociety Consensus Position Statement on Prostatic Artery Embolization for Treatment of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: From the Society of Interventional Radiology, the Cardiovascular and Interventional Radiological Society of Europe, Société Française de Radiologie, and the British Society of Interventional Radiology: Endorsed by the Asia Pacific Society of Cardiovascular and Interventional Radiology, Canadian Association for Interventional Radiology, Chinese College of Interventionalists, Interventional Radiology Society of Australasia, Japanese Society of Interventional Radiology, and Korean Society of Interventional Radiology. J Vasc Interv Radiol 2019; 30: 627–37CrossRef
3.
Zurück zum Zitat Malling B et al. Prostate artery embolisation for benign prostatic hyperplasia: A systematic review and meta-analysis. Eur Radiol 2019; 29: 287–98CrossRef Malling B et al. Prostate artery embolisation for benign prostatic hyperplasia: A systematic review and meta-analysis. Eur Radiol 2019; 29: 287–98CrossRef
4.
Zurück zum Zitat NICE Guidance - Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia: © NICE (2018) Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia. BJU Int. 2018; 122: 11–2 NICE Guidance - Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia: © NICE (2018) Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia. BJU Int. 2018; 122: 11–2
5.
Zurück zum Zitat Hacking N et al. Technical and Imaging Outcomes from the UK Registry of Prostate Artery Embolization (UK-ROPE) Study: Focusing on Predictors of Clinical Success. Cardiovasc Intervent Radiol. 2019; 42: 666–76CrossRef Hacking N et al. Technical and Imaging Outcomes from the UK Registry of Prostate Artery Embolization (UK-ROPE) Study: Focusing on Predictors of Clinical Success. Cardiovasc Intervent Radiol. 2019; 42: 666–76CrossRef
6.
Zurück zum Zitat Teichgräber U et al. Prostataarterienembolisation: Indikation, Technik und klinische Ergebnisse. Fortschr Röntgenstr. 2018; 190: 847–55CrossRef Teichgräber U et al. Prostataarterienembolisation: Indikation, Technik und klinische Ergebnisse. Fortschr Röntgenstr. 2018; 190: 847–55CrossRef
7.
Zurück zum Zitat Maclean D et al. Factors Predicting a Good Symptomatic Outcome After Prostate Artery Embolisation (PAE). Cardiovasc Intervent Radiol. 2018; 41: 1152–9CrossRef Maclean D et al. Factors Predicting a Good Symptomatic Outcome After Prostate Artery Embolisation (PAE). Cardiovasc Intervent Radiol. 2018; 41: 1152–9CrossRef
8.
Zurück zum Zitat Kovács A. Prostataarterienembolisation (PAE): Technik und Ergebnisse. Radiologe. 2017; 57: 641–51CrossRef Kovács A. Prostataarterienembolisation (PAE): Technik und Ergebnisse. Radiologe. 2017; 57: 641–51CrossRef
9.
Zurück zum Zitat Carnevale FC et al. Transurethral Resection of the Prostate (TURP) Versus Original and PErFecTED Prostate Artery Embolization (PAE) Due to Benign Prostatic Hyperplasia (BPH): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled Analysis. Cardiovasc Intervent Radiol. 2016; 39: 44–52CrossRef Carnevale FC et al. Transurethral Resection of the Prostate (TURP) Versus Original and PErFecTED Prostate Artery Embolization (PAE) Due to Benign Prostatic Hyperplasia (BPH): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled Analysis. Cardiovasc Intervent Radiol. 2016; 39: 44–52CrossRef
10.
Zurück zum Zitat Carnevale FC et al. Anatomical Variants in Prostate Artery Embolization: A Pictorial Essay. Cardiovasc Intervent Radiol. 2017; 40: 1321–37CrossRef Carnevale FC et al. Anatomical Variants in Prostate Artery Embolization: A Pictorial Essay. Cardiovasc Intervent Radiol. 2017; 40: 1321–37CrossRef
11.
Zurück zum Zitat Bilhim T et al. Radiological anatomy of prostatic arteries. Tech Vasc Interv Radiol. 2012; 15: 276–85CrossRef Bilhim T et al. Radiological anatomy of prostatic arteries. Tech Vasc Interv Radiol. 2012; 15: 276–85CrossRef
12.
Zurück zum Zitat de Assis AM et al. Pelvic Arterial Anatomy Relevant to Prostatic Artery Embolisation and Proposal for Angiographic Classification. Cardiovasc Intervent Radiol. 2015; 38: 855–61CrossRef de Assis AM et al. Pelvic Arterial Anatomy Relevant to Prostatic Artery Embolisation and Proposal for Angiographic Classification. Cardiovasc Intervent Radiol. 2015; 38: 855–61CrossRef
13.
Zurück zum Zitat Maclean D et al. Planning Prostate Artery Embolisation: Is it Essential to Perform a Pre-procedural CTA? Cardiovasc Intervent Radiol. 2018; 41: 628–32CrossRef Maclean D et al. Planning Prostate Artery Embolisation: Is it Essential to Perform a Pre-procedural CTA? Cardiovasc Intervent Radiol. 2018; 41: 628–32CrossRef
14.
Zurück zum Zitat Sun F et al. Prostatic Artery Embolization (PAE) for Symptomatic Benign Prostatic Hyperplasia (BPH): Part 2, Insights into the Technical Rationale. Cardiovasc Intervent Radiol. 2016; 39: 161–9CrossRef Sun F et al. Prostatic Artery Embolization (PAE) for Symptomatic Benign Prostatic Hyperplasia (BPH): Part 2, Insights into the Technical Rationale. Cardiovasc Intervent Radiol. 2016; 39: 161–9CrossRef
15.
Zurück zum Zitat Pisco J et al. Prostatic arterial embolization for benign prostatic hyperplasia: Short- and intermediate-term results. Radiology. 2013; 266: 668–77CrossRef Pisco J et al. Prostatic arterial embolization for benign prostatic hyperplasia: Short- and intermediate-term results. Radiology. 2013; 266: 668–77CrossRef
16.
Zurück zum Zitat Abt D et al. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: Randomised, open label, non-inferiority trial. BMJ. 2018; 361: k2338CrossRef Abt D et al. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: Randomised, open label, non-inferiority trial. BMJ. 2018; 361: k2338CrossRef
17.
Zurück zum Zitat Christidis D et al. Prostatic artery embolization for benign prostatic obstruction: Assessment of safety and efficacy. World J Urol. 2018; 36: 575–84CrossRef Christidis D et al. Prostatic artery embolization for benign prostatic obstruction: Assessment of safety and efficacy. World J Urol. 2018; 36: 575–84CrossRef
18.
Zurück zum Zitat Gao Y-a et al. Benign prostatic hyperplasia: Prostatic arterial embolization versus transurethral resection of the prostate—a prospective, randomized, and controlled clinical trial. Radiology. 2014; 270: 920–8CrossRef Gao Y-a et al. Benign prostatic hyperplasia: Prostatic arterial embolization versus transurethral resection of the prostate—a prospective, randomized, and controlled clinical trial. Radiology. 2014; 270: 920–8CrossRef
19.
Zurück zum Zitat Culp SH. Prostatic Artery Chemoembolization-A Viable Management Option for Men Diagnosed with Prostate Cancer? J Vasc Interv Radiol. 2018;29:306CrossRef Culp SH. Prostatic Artery Chemoembolization-A Viable Management Option for Men Diagnosed with Prostate Cancer? J Vasc Interv Radiol. 2018;29:306CrossRef
20.
Zurück zum Zitat Tapping CR et al. Prostatic artery embolization (PAE) for prostatic origin bleeding in the context of prostate malignancy. Acta Radiol Open. 2019; 8: 2058460119846061.PubMedPubMedCentral Tapping CR et al. Prostatic artery embolization (PAE) for prostatic origin bleeding in the context of prostate malignancy. Acta Radiol Open. 2019; 8: 2058460119846061.PubMedPubMedCentral
21.
Zurück zum Zitat Mordasini L et al. Prostatic Artery Embolization in the Treatment of Localized Prostate Cancer: A Bicentric Prospective Proof-of-Concept Study of 12 Patients. J Vasc Interv Radiol. 2018;29:589–97CrossRef Mordasini L et al. Prostatic Artery Embolization in the Treatment of Localized Prostate Cancer: A Bicentric Prospective Proof-of-Concept Study of 12 Patients. J Vasc Interv Radiol. 2018;29:589–97CrossRef
22.
Zurück zum Zitat Abt D et al. Outcome prediction of prostatic artery embolization: Post hoc analysis of a randomized, open-label, non-inferiority trial. BJU Int. 2019; 124: 134–44CrossRef Abt D et al. Outcome prediction of prostatic artery embolization: Post hoc analysis of a randomized, open-label, non-inferiority trial. BJU Int. 2019; 124: 134–44CrossRef
23.
Zurück zum Zitat Little MW et al. Adenomatous-Dominant Benign Prostatic Hyperplasia (AdBPH) as a Predictor for Clinical Success Following Prostate Artery Embolization: An Age-Matched Case-Control Study. Cardiovasc Intervent Radiol. 2017; 40: 682–9CrossRef Little MW et al. Adenomatous-Dominant Benign Prostatic Hyperplasia (AdBPH) as a Predictor for Clinical Success Following Prostate Artery Embolization: An Age-Matched Case-Control Study. Cardiovasc Intervent Radiol. 2017; 40: 682–9CrossRef
Metadaten
Titel
Neuer Therapieansatz für BPH/LUTS
Prostataarterienembolisation — Hintergrund, Technik und Ergebnisse
verfasst von
Prof. Dr. med. Thomas J. Vogl
Annette Zinn
Leona S. Alizadeh
Christian Booz
Nagy N. Naguib
Publikationsdatum
31.08.2019
Verlag
Springer Medizin
Erschienen in
Uro-News / Ausgabe 9/2019
Print ISSN: 1432-9026
Elektronische ISSN: 2196-5676
DOI
https://doi.org/10.1007/s00092-019-2068-6

Weitere Artikel der Ausgabe 9/2019

Uro-News 9/2019 Zur Ausgabe

Praxis konkret

Yoga für Urologen